This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AIG, DOW, EZPW, FOSL

Scotts Miracle Gro (SMG) was upgraded at BMO Capital Markets to Market Perform from Underperform. $42 price target. Stock fell 16% on earnings, BMO Capital Markets said.

St. Jude (STJ) was upgraded at Morgan Stanley from Equal-Weight to Overweight. $52 price target. Company is leveraged to growth in new cardio markets and can expand margins, Morgan Stanley said.

Under Armour (UA - Get Report) was initiated with a Buy rating at Benchmark. $104 price target. Stock is attractively valued, following a recent pullback, Benchmark said.

Veeco Instruments (VECO) was upgraded at Piper Jaffray from Neutral to Overweight. $50 price target. Company is positioned well for the next upcycle, Piper Jaffray said.

Zynga (ZNGA) was initiated with a Buy rating at Citigroup. $12 price target. Attractive valuation with room to grow, Citi said.

STOCK COMMENTS / EPS CHANGES

Amedisys (AMED) numbers were lowered at Jefferies. Shares are now seen reaching $15. Estimates were also lowered on reimbursement uncertainty, Jefferies said. Hold rating.

Franklin Resources (BEN) numbers were reduced at BMO Capital. Estimates were cut through 2013. Market pullback is weighing on assets, BMO said. Market Perform rating and new $133 price target.

Buckeye Partners (BPL) numbers were cut at UBS. Shares are now seen reaching $64. Estimates were also trimmed on broad weakness that dragged down the first quarter, UBS said. Buy rating.

Walt Disney (DIS) numbers were raised at Credit Suisse. Shares are now seen reaching $50. Estimates were also increased, given higher growth in cable, parks and broadcasting, Credit Suisse said. Outperform rating.

Dollar Tree (DLTR) numbers were boosted at BMO Capital. Shares are now seen reaching $117. Estimates were also boosted, given higher expected comp sales growth, BMO Capital said. Outperform rating.

Generac numbers were raised at Oppenheimer. Shares are now seen reaching $34. Estimates were also raised on robust first quarter, Oppenheimer said. Outperform rating.

Huntington Bancshares (HBAN) numbers were raised at Bank of America/Merrill Lynch. Estimates were raised through 2013. Company should see lower credit losses, BofA/Merrill said. Buy rating and new $7.25 price target.

Hartford Financial Group (HIG) numbers were lowered at UBS. Shares are now seen reaching $33. Estimates were also lowered as recent actions are good, but management must execute, UBS said. Buy rating.

NetApp (NTAP) estimates, price target were reduced at BMO Capital. Shares are now seen reaching $45. Estimates were also cut, as EMC (EMC) appears to be gaining market share with aggressive pricing. Outperform rating.

Transdigm (NTAP) estimates, price target were increased at Credit Suisse. Estimates were raised through 2014. Acquisitions are adding to growth, and the company is seeing solid pricing, Credit Suisse said. Outperform rating and new $151 price target.

Tempur-Pedic (TPX) price target was lowered at Oppenheimer to $75. Substantial drop in shares, Oppenheimer said. Outperform rating.

Vitamin Shoppe (VSI) numbers were increased at BMO Capital. Estimates were raised through 2013. Comp sales growth is accelerating, BMO said. Market Perform rating and new $55 price target.

Wendy's (WEN) estimates, price target were reduced at BMO Capital. Shares are now seen reaching $5. Estimates were also cut, given the company's new guidance, BMO Capital said. Market Perform rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AIG $63.86 0.35%
DOW $45.99 0.04%
EZPW $6.02 -0.17%
FOSL $68.01 0.07%
UA $97.03 1.00%

Markets

Chart of I:DJI
DOW 17,500.62 +60.03 0.34%
S&P 500 2,067.64 -12.01 -0.58%
NASDAQ 5,039.7760 -48.8540 -0.96%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs